Breaking News

GenScript Expands CDMO Capabilities

Launches CDMO segment "GenScript ProBio" dedicated to providing services from discovery to commercialization.

By: Contract Pharma

Contract Pharma Staff

The inaugural GenScript Cell and Gene Therapy Industry Development & Cooperation Forum concluded in Shanghai on July 17, at which more than 700 researchers and corporate leaders shared insights on the future growth of the cell and gene industry.   At the event, GenScript unveiled the integration and upgrading of the original CDMO platform and the release of its latest brand, GenScript ProBio. The new brand is dedicated to providing end-to-end service from discovery to commercialization.  ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters